MPS Pharmaa Ltd | 7.61 Cr. | 3.98 | 4.33/3.05 | | 0.80 | 0.00 % | 9.15 % | 34.9 % | 10.0 |
Gujarat Themis Biosyn Ltd | 2,667 Cr. | 245 | 390/210 | 50.6 | 20.5 | 0.25 % | 45.0 % | 33.8 % | 1.00 |
Gujarat Terce Laboratories Ltd | 54.9 Cr. | 74.0 | 94.9/28.0 | 18.6 | 11.9 | 0.00 % | 9.72 % | 3.44 % | 10.0 |
Gujarat Inject (Kerala) Ltd | 37.8 Cr. | 25.8 | 28.6/8.74 | 38.6 | 6.64 | 0.00 % | 2.65 % | 2.08 % | 10.0 |
Godavari Drugs Ltd | 75.3 Cr. | 100 | 155/87.0 | 11.3 | 55.4 | 0.00 % | 14.4 % | 15.5 % | 10.0 |
Glenmark Life Sciences Ltd | 13,316 Cr. | 1,084 | 1,335/666 | 31.4 | 207 | 2.07 % | 28.1 % | 21.1 % | 2.00 |
Gennex Laboratories Ltd | 279 Cr. | 12.2 | 29.0/11.5 | 16.1 | 7.93 | 0.00 % | 14.1 % | 10.2 % | 1.00 |
Ganga Pharmaceuticals Ltd | 8.22 Cr. | 17.0 | 27.1/13.3 | 164 | 14.6 | 0.00 % | 3.06 % | 0.80 % | 10.0 |
Fredun Pharmaceuticals Ltd | 342 Cr. | 728 | 1,054/635 | 18.2 | 278 | 0.10 % | 17.1 % | 14.3 % | 10.0 |
Fervent Synergies Ltd | 93.8 Cr. | 21.4 | 32.0/14.6 | | 8.11 | 0.00 % | 34.8 % | 34.9 % | 10.0 |
Fermenta Biotech Ltd | 1,009 Cr. | 343 | 449/145 | 28.6 | 98.6 | 0.36 % | 3.20 % | 5.59 % | 5.00 |
Fabino Enterprises Ltd | 6.67 Cr. | 31.8 | 41.8/23.6 | 133 | 20.0 | 0.00 % | 1.68 % | 1.21 % | 10.0 |
Evoq Remedies Ltd | 16.8 Cr. | 6.75 | 14.0/6.62 | 37.4 | 18.6 | 0.00 % | 1.91 % | 1.80 % | 10.0 |
Everest Organics Ltd | 250 Cr. | 257 | 307/110 | | 50.6 | 0.00 % | 6.05 % | 0.30 % | 10.0 |
Entero Healthcare Solutions Ltd | 5,717 Cr. | 1,314 | 1,584/970 | 80.0 | 387 | 0.00 % | 6.71 % | 4.98 % | 10.0 |
Murae Organisor Ltd | 189 Cr. | 2.03 | 2.81/1.03 | 40.1 | 2.85 | 0.00 % | 0.79 % | 0.13 % | 2.00 |
Dipna Pharmachem Ltd | 33.7 Cr. | 14.0 | 16.6/6.40 | 40.6 | 15.8 | 0.00 % | 7.05 % | 3.52 % | 10.0 |
Decipher Labs Ltd | 13.7 Cr. | 13.5 | 24.6/13.4 | 16.5 | 21.3 | 0.00 % | 3.09 % | 6.75 % | 10.0 |
Coral Laboratories Ltd | 261 Cr. | 730 | 999/345 | 11.2 | 570 | 0.28 % | 12.6 % | 9.58 % | 10.0 |
Concord Drugs Ltd | 33.9 Cr. | 33.9 | 45.0/28.5 | | 33.9 | 0.00 % | 4.48 % | 1.28 % | 10.0 |
Colinz Laboratories Ltd | 24.2 Cr. | 52.9 | 84.4/36.0 | 49.4 | 20.5 | 0.00 % | 7.70 % | 5.73 % | 10.0 |
Cian Healthcare Ltd | 8.66 Cr. | 3.46 | 26.5/2.97 | 34.6 | 23.1 | 0.00 % | 5.22 % | 0.43 % | 10.0 |
Chemo Pharma Laboratories Ltd | 9.78 Cr. | 65.2 | 154/52.2 | 24.5 | 91.1 | 0.00 % | 13.3 % | 9.67 % | 10.0 |
Checkpoint Trends Ltd | 7.73 Cr. | 14.2 | 17.4/6.08 | | 0.93 | 0.00 % | 3.36 % | 5.77 % | 10.0 |
Chandra Bhagat Pharma Ltd | 47.5 Cr. | 63.0 | 148/60.0 | 30.1 | 39.4 | 0.00 % | 7.95 % | 5.42 % | 10.0 |
Brawn Biotech Ltd | 6.30 Cr. | 21.0 | 27.8/14.6 | | 14.1 | 0.00 % | 25.9 % | 21.8 % | 10.0 |
Blue Jet Healthcare Ltd | 13,760 Cr. | 793 | 845/329 | 58.6 | 53.3 | 0.13 % | 30.0 % | 22.4 % | 2.00 |
Bharat Immunological & Biological Corporation Ltd | 97.7 Cr. | 22.6 | 37.5/21.8 | | 18.2 | 0.00 % | 9.27 % | 17.7 % | 10.0 |
Beryl Drugs Ltd | 16.4 Cr. | 32.4 | 46.0/26.0 | 206 | 18.3 | 0.00 % | 11.6 % | 8.95 % | 10.0 |
BDH Industries Ltd | 177 Cr. | 308 | 418/255 | 18.2 | 110 | 1.46 % | 20.6 % | 16.9 % | 10.0 |
Bacil Pharma Ltd | 26.6 Cr. | 45.1 | 62.6/8.14 | 75.8 | 2.87 | 0.00 % | 13.1 % | 13.8 % | 10.0 |
Aurobindo Pharma Ltd | 67,207 Cr. | 1,147 | 1,593/958 | 18.9 | 527 | 0.39 % | 14.1 % | 11.5 % | 1.00 |
Auro Laboratories Ltd | 133 Cr. | 213 | 307/137 | 21.5 | 69.6 | 0.00 % | 20.4 % | 20.5 % | 10.0 |
Anuh Pharma Ltd | 882 Cr. | 176 | 265/173 | 17.6 | 60.5 | 1.43 % | 25.6 % | 19.5 % | 5.00 |
ANG Lifesciences India Ltd | 51.4 Cr. | 39.4 | 68.7/37.0 | | 56.2 | 0.00 % | 1.78 % | 8.72 % | 10.0 |
Ami Organics Ltd | 9,677 Cr. | 2,364 | 2,644/1,004 | 79.6 | 294 | 0.13 % | 16.0 % | 9.37 % | 10.0 |
Amerise Biosciences Ltd | 6.00 Cr. | 0.91 | 1.45/0.55 | | 0.80 | 0.00 % | 2.73 % | 2.75 % | 1.00 |
Ambalal Sarabhai Enterprises Ltd | 370 Cr. | 48.3 | 77.7/39.2 | 27.8 | 18.3 | 0.00 % | 7.08 % | 4.22 % | 10.0 |
Adline Chem Lab Ltd | 10.0 Cr. | 17.1 | 27.3/11.9 | | 2.70 | 0.00 % | % | % | 10.0 |
Achyut Healthcare Ltd | 102 Cr. | 4.31 | 6.25/2.87 | 154 | 1.32 | 0.00 % | 3.27 % | 2.52 % | 1.00 |
Abbott India Ltd | 60,987 Cr. | 28,700 | 30,683/25,200 | 45.7 | 1,657 | 1.43 % | 46.0 % | 34.9 % | 10.0 |
Aarti Pharmalabs Ltd | 6,770 Cr. | 747 | 771/381 | 27.2 | 205 | 0.40 % | 16.6 % | 13.1 % | 5.00 |
Aarey Drugs & Pharmaceuticals Ltd | 130 Cr. | 46.5 | 75.8/37.0 | 18.8 | 48.5 | 0.00 % | 6.09 % | 3.74 % | 10.0 |
Zota Health Care Ltd | 2,556 Cr. | 933 | 1,078/440 | | 58.0 | 0.11 % | 7.32 % | 16.8 % | 10.0 |
Wockhardt Ltd | 23,721 Cr. | 1,460 | 1,680/421 | | 209 | 0.00 % | 0.83 % | 12.1 % | 5.00 |
Wanbury Ltd | 705 Cr. | 215 | 325/122 | 25.6 | 11.8 | 0.00 % | 60.6 % | % | 10.0 |
Vivimed Labs Ltd | 41.0 Cr. | 4.95 | / | | 3.12 | 0.00 % | 9.38 % | 233 % | 2.00 |
Venus Remedies Ltd | 444 Cr. | 332 | 428/270 | 15.9 | 370 | 0.00 % | 8.57 % | 5.94 % | 10.0 |
Unichem Laboratories Ltd | 4,926 Cr. | 700 | 950/433 | 58.2 | 341 | 0.00 % | 0.39 % | 1.17 % | 2.00 |
TTK Healthcare Ltd | 1,733 Cr. | 1,227 | 1,923/1,209 | 25.3 | 735 | 0.81 % | 8.67 % | 6.43 % | 10.0 |
Torrent Pharmaceuticals Ltd | 1,03,654 Cr. | 3,063 | 3,591/2,488 | 55.7 | 222 | 0.91 % | 23.2 % | 24.2 % | 5.00 |
Themis Medicare Ltd | 1,895 Cr. | 206 | 317/181 | 35.8 | 44.8 | 0.24 % | 13.5 % | 11.8 % | 1.00 |
Syncom Formulations (India) Ltd | 1,684 Cr. | 17.9 | 27.9/11.0 | 44.2 | 3.32 | 0.00 % | 10.2 % | 8.51 % | 1.00 |
Suven Pharmaceuticals Ltd | 26,858 Cr. | 1,055 | 1,360/597 | 111 | 77.7 | 0.00 % | 18.8 % | 14.1 % | 1.00 |
Suven Life Sciences Ltd | 2,695 Cr. | 124 | 169/83.0 | | 8.84 | 0.00 % | 36.4 % | 36.3 % | 1.00 |
Sun Pharmaceuticals Industries Ltd | 4,09,063 Cr. | 1,705 | 1,960/1,377 | 34.7 | 288 | 0.80 % | 17.3 % | 16.7 % | 1.00 |
Solara Active Pharma Sciences Ltd | 2,136 Cr. | 506 | 886/322 | | 301 | 0.00 % | 8.67 % | 33.5 % | 10.0 |
SMS Pharmaceuticals Ltd | 1,732 Cr. | 205 | 398/140 | 29.5 | 70.6 | 0.20 % | 11.2 % | 9.27 % | 1.00 |
SMS Lifesciences India Ltd | 359 Cr. | 1,188 | 1,750/549 | 17.7 | 621 | 0.13 % | 6.89 % | 3.66 % | 10.0 |
Shilpa Medicare Ltd | 6,527 Cr. | 667 | 960/358 | 77.2 | 238 | 0.00 % | 5.25 % | 1.71 % | 1.00 |
Sequent Scientific Ltd | 3,691 Cr. | 147 | 241/91.8 | 245 | 27.2 | 0.00 % | 0.44 % | 3.09 % | 2.00 |
Sanofi India Ltd | 12,367 Cr. | 5,370 | 7,600/4,606 | 29.3 | 298 | 3.11 % | 71.1 % | 51.5 % | 10.0 |
RPG Life Sciences Ltd | 3,829 Cr. | 2,315 | 2,977/1,360 | 40.1 | 229 | 0.70 % | 34.6 % | 25.5 % | 8.00 |
Procter & Gamble Health Ltd | 8,606 Cr. | 5,184 | 5,850/4,637 | 38.0 | 324 | 1.15 % | 45.0 % | 33.5 % | 10.0 |
Pharmaids Pharmaceuticals Ltd | 235 Cr. | 66.7 | 87.5/31.9 | | 19.0 | 0.00 % | 27.6 % | 16.8 % | 10.0 |
Pfizer Ltd | 18,768 Cr. | 4,102 | 6,453/3,950 | 30.5 | 820 | 0.86 % | 22.0 % | 16.1 % | 10.0 |
Par Drugs & Chemicals Ltd | 207 Cr. | 168 | 348/165 | 11.3 | 78.6 | 0.00 % | 25.0 % | 18.5 % | 10.0 |
Panacea Biotec Ltd | 2,174 Cr. | 355 | 491/112 | | 136 | 0.00 % | 3.57 % | 3.17 % | 1.00 |
Ortin Laboratories Ltd | 16.4 Cr. | 20.1 | 26.4/16.2 | | 3.47 | 0.00 % | 60.2 % | 118 % | 10.0 |
Orchid Pharma Ltd | 6,237 Cr. | 1,230 | 1,998/913 | 52.4 | 241 | 0.00 % | 9.37 % | 9.94 % | 10.0 |
Neuland Laboratories Ltd | 17,442 Cr. | 13,595 | 18,100/5,532 | 72.7 | 1,087 | 0.10 % | 33.3 % | 26.4 % | 10.0 |
Nectar Lifescience Ltd | 720 Cr. | 32.1 | 56.5/26.2 | 42.4 | 48.1 | 0.00 % | 5.97 % | 0.46 % | 1.00 |
Natco Pharma Ltd | 21,676 Cr. | 1,210 | 1,639/848 | 11.2 | 399 | 0.76 % | 30.1 % | 25.9 % | 2.00 |
Morepen Laboratories Ltd | 3,085 Cr. | 56.3 | 101/38.6 | 24.5 | 20.3 | 0.00 % | 16.8 % | 12.0 % | 2.00 |
Marksans Pharma Ltd | 11,415 Cr. | 252 | 359/126 | 31.0 | 50.3 | 0.24 % | 20.6 % | 16.5 % | 1.00 |
Mangalam Drugs and Organics Ltd | 176 Cr. | 111 | 145/85.2 | 18.7 | 93.2 | 0.00 % | 1.19 % | 6.12 % | 10.0 |
Lyka Labs Ltd | 453 Cr. | 127 | 177/97.9 | 111 | 27.7 | 0.00 % | 3.53 % | 5.07 % | 10.0 |
Lupin Ltd | 93,599 Cr. | 2,049 | 2,403/1,493 | 32.7 | 343 | 0.39 % | 15.7 % | 14.1 % | 2.00 |
Lincoln Pharmaceuticals Ltd | 1,342 Cr. | 670 | 980/498 | 13.9 | 319 | 0.28 % | 22.3 % | 16.8 % | 10.0 |
Laurus Labs Ltd | 32,347 Cr. | 600 | 646/372 | 129 | 79.2 | 0.13 % | 7.50 % | 5.43 % | 2.00 |
Kwality Pharmaceuticals Ltd | 788 Cr. | 759 | 1,070/405 | 22.4 | 234 | 0.00 % | 15.9 % | 13.7 % | 10.0 |
Krebs Biochemicals & Industries Ltd | 194 Cr. | 90.0 | 129/60.0 | | 60.4 | 0.00 % | 19.0 % | % | 10.0 |
Kopran Ltd | 834 Cr. | 173 | 370/162 | 17.5 | 103 | 1.76 % | 13.8 % | 11.0 % | 10.0 |
Kilitch Drugs (India) Ltd | 507 Cr. | 315 | 435/298 | 28.3 | 118 | 0.00 % | 12.6 % | 7.71 % | 10.0 |
Jubilant Pharmova Ltd | 15,569 Cr. | 977 | 1,310/538 | 46.7 | 373 | 0.51 % | 6.74 % | 0.76 % | 1.00 |
J B Chemicals & Pharmaceuticals Ltd | 24,531 Cr. | 1,576 | 2,030/1,474 | 38.3 | 207 | 0.80 % | 24.6 % | 20.0 % | 1.00 |
Jagsonpal Pharmaceuticals Ltd | 1,595 Cr. | 240 | 328/108 | 43.8 | 29.7 | 0.79 % | 17.0 % | 13.0 % | 2.00 |
Ipca Laboratories Ltd | 36,133 Cr. | 1,424 | 1,758/1,052 | 58.0 | 264 | 0.28 % | 12.8 % | 9.35 % | 1.00 |
IOL Chemicals & Pharmaceuticals Ltd | 2,120 Cr. | 361 | 538/331 | 21.2 | 283 | 1.41 % | 12.3 % | 8.68 % | 10.0 |
Ind-Swift Ltd | 76.1 Cr. | 14.0 | 34.7/13.7 | 1.18 | 122 | 0.00 % | 13.4 % | % | 2.00 |
Ind-Swift Laboratories Ltd | 538 Cr. | 91.0 | 186/85.6 | 5.27 | 171 | 0.00 % | 19.6 % | 17.4 % | 10.0 |
Indoco Remedies Ltd | 2,339 Cr. | 254 | 388/242 | | 118 | 0.60 % | 10.4 % | 8.33 % | 2.00 |
Hikal Ltd | 4,360 Cr. | 354 | 465/260 | 58.5 | 97.6 | 0.33 % | 7.79 % | 5.97 % | 2.00 |
Hester Biosciences Ltd | 1,503 Cr. | 1,767 | 3,379/1,293 | 48.6 | 355 | 0.34 % | 9.32 % | 6.60 % | 10.0 |
Gufic BioSciences Ltd | 3,796 Cr. | 378 | 504/278 | 44.7 | 57.3 | 0.03 % | 17.2 % | 20.0 % | 1.00 |
Granules India Ltd | 13,141 Cr. | 542 | 725/382 | 27.4 | 141 | 0.27 % | 15.4 % | 13.4 % | 1.00 |
Glenmark Pharmaceuticals Ltd | 40,052 Cr. | 1,419 | 1,831/767 | | 299 | 0.17 % | 12.3 % | 50.9 % | 1.00 |
Glaxosmithkline Pharmaceuticals Ltd | 34,562 Cr. | 2,040 | 3,088/1,825 | 43.1 | 98.7 | 1.56 % | 51.3 % | 37.3 % | 10.0 |
Gland Pharma Ltd | 23,804 Cr. | 1,445 | 2,221/1,413 | 21.2 | 557 | 1.42 % | 16.7 % | 12.3 % | 1.00 |
FDC Ltd | 7,337 Cr. | 451 | 659/405 | 23.1 | 141 | 1.09 % | 18.4 % | 14.2 % | 1.00 |
ERIS Lifesciences Ltd | 17,751 Cr. | 1,304 | 1,594/809 | 53.9 | 204 | 0.54 % | 11.3 % | 16.3 % | 1.00 |
Dr Reddys Laboratories Ltd | 1,01,412 Cr. | 1,215 | 1,421/1,120 | 18.9 | 369 | 0.66 % | 26.5 % | 21.4 % | 1.00 |
Dishman Carbogen Amcis Ltd | 3,594 Cr. | 229 | 308/133 | | 366 | 0.00 % | 0.02 % | 2.64 % | 2.00 |
Cipla Ltd | 1,17,112 Cr. | 1,450 | 1,702/1,317 | 23.5 | 351 | 0.87 % | 22.8 % | 16.8 % | 2.00 |
Caplin Point Laboratories Ltd | 15,926 Cr. | 2,095 | 2,641/1,221 | 31.0 | 334 | 0.25 % | 26.5 % | 24.2 % | 2.00 |
Brooks Laboratories Ltd | 352 Cr. | 134 | 203/72.5 | | 22.6 | 0.00 % | 24.7 % | 28.1 % | 10.0 |
Bliss GVS Pharma Ltd | 1,475 Cr. | 140 | 186/92.2 | 17.4 | 95.8 | 0.36 % | 14.4 % | 10.2 % | 1.00 |
Biofil Chemicals & Pharmaceuticals Ltd | 82.5 Cr. | 50.7 | 92.0/49.0 | 137 | 11.3 | 0.00 % | 4.94 % | 4.00 % | 10.0 |
Biocon Ltd | 42,891 Cr. | 357 | 405/244 | 52.2 | 175 | 0.14 % | 5.96 % | 5.25 % | 5.00 |
Beta Drugs Ltd | 1,610 Cr. | 1,675 | 2,326/1,060 | 39.3 | 188 | 0.00 % | 32.8 % | 26.0 % | 10.0 |
Bal Pharma Ltd | 157 Cr. | 98.4 | 158/89.0 | 20.6 | 43.2 | 1.21 % | 12.1 % | 11.0 % | 10.0 |
Bafna Pharmaceuticals Ltd | 186 Cr. | 78.8 | 113/73.2 | 39.9 | 35.0 | 0.00 % | 9.48 % | 9.44 % | 10.0 |
Astrazeneca Pharma India Ltd | 18,901 Cr. | 7,560 | 8,140/4,050 | 113 | 272 | 0.31 % | 31.1 % | 22.9 % | 2.00 |
Amrutanjan Health Care Ltd | 1,821 Cr. | 630 | 863/591 | 38.3 | 103 | 0.72 % | 21.3 % | 15.5 % | 1.00 |
Alpa Laboratories Ltd | 213 Cr. | 101 | 145/69.9 | 10.2 | 83.0 | 0.00 % | 13.7 % | 11.2 % | 10.0 |
Alkem Laboratories Ltd | 55,902 Cr. | 4,675 | 6,440/4,407 | 25.9 | 961 | 0.85 % | 19.7 % | 19.6 % | 2.00 |
Alembic Pharmaceuticals Ltd | 16,624 Cr. | 846 | 1,304/823 | 28.0 | 249 | 1.25 % | 13.1 % | 13.3 % | 2.00 |
Albert David Ltd | 650 Cr. | 1,138 | 1,754/1,010 | 9.47 | 724 | 1.01 % | 27.8 % | 21.7 % | 10.0 |
Ajanta Pharma Ltd | 31,445 Cr. | 2,517 | 3,486/1,998 | 35.0 | 294 | 1.42 % | 31.6 % | 23.2 % | 2.00 |
Advanced Enzyme Technologies Ltd | 3,524 Cr. | 315 | 571/302 | 24.7 | 120 | 1.62 % | 15.2 % | 11.2 % | 2.00 |
Aarti Drugs Limited | 3,590 Cr. | 390 | 635/379 | 27.2 | 126 | 0.25 % | 13.7 % | 12.4 % | 10.0 |
Industry Average | 17,682.14 Cr | 1,098.51 | | 44.94 | 184.84 | 0.35% | 16.18% | 16.43% | 6.27 |